Novo Nordisk A S (NVO) income statement
NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 4/30
$39.43−1.27 (-3.12%)
Close on Nov 18, 2026Market cap $176.06BP/E 11.6Yield –
Novo Nordisk A S income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 81.0%
- Operating margin
- 41.3%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.80
- Debt to equity
- –
- Debt to assets
- 26.3%
- Cash to current liabilities
- 12.3%
Valuation
- P/E ratio
- 11.6
- Price to sales
- 3.86
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?